Last $161.44 USD
Change Today -0.12 / -0.07%
Volume 3.1M
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for alexion pharmaceuticals inc (ALXN)

Year over year, Alexion Pharmaceuticals, Inc. has seen little change in their bottom line (from $254.8M USD to $252.9M USD) despite revenues that grew from $1.1B USD to $1.6B USD. A key factor has been an increase in the percentage of sales devoted to income tax expenses from 12.59% to 17.62%.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Reclassified
Dec 31
2012
Dec 31
2013
4 Year
Trend
Revenues541.0783.41,134.11,551.3
TOTAL REVENUES541.0783.41,134.11,551.3
Cost of Goods Sold64.493.1126.2168.4
GROSS PROFIT476.5690.31,007.91,383.0
Selling General & Admin Expenses, Total226.8308.2384.7489.7
R&D Expenses98.4137.4222.7317.1
Depreciation & Amortization, Total--0.40.40.4
OTHER OPERATING EXPENSES, TOTAL325.2446.0607.8807.2
OPERATING INCOME151.4244.3400.1575.7
Interest Expense-0.7-0.8-7.4-4.1
Interest and Investment Income1.51.91.83.3
NET INTEREST EXPENSE0.81.1-5.6-0.8
Currency Exchange Gains (Loss)-2.4-2.3-1.2-1.0
EBT, EXCLUDING UNUSUAL ITEMS149.7243.2393.3574.0
Merger & Restructuring Charges-0.7-13.5-22.8-5.0
Other Unusual Items, Total----27.1-42.7
In Process R&D Expenses-----26.3-33.5
Other Unusual Items----53.4-9.2
EBT, INCLUDING UNUSUAL ITEMS149.0229.7397.6526.3
Income Tax Expense52.054.4142.7273.4
Earnings from Continuing Operations97.0175.3254.8252.9
NET INCOME97.0175.3254.8252.9
NET INCOME TO COMMON INCLUDING EXTRA ITEMS97.0175.3254.8252.9
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS97.0175.3254.8252.9
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $161.44 USD -0.12

ALXN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 3,223 INR 0.00
Illumina Inc $172.26 USD -5.66
Regeneron Pharmaceuticals Inc $358.92 USD -3.82
Sigma-Aldrich Corp $102.37 USD -0.93
Vertex Pharmaceuticals Inc $103.75 USD +6.40
View Industry Companies
 

Industry Analysis

ALXN

Industry Average

Valuation ALXN Industry Range
Price/Earnings 81.2x
Price/Sales 16.6x
Price/Book 11.1x
Price/Cash Flow 79.7x
TEV/Sales 15.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.